Proton beam therapy may offer gentler radiation for esophageal cancer

This study looks at whether proton beam therapy, a precise form of radiation, causes fewer severe side effects than standard radiation (IMRT) for people with esophageal cancer. About 22 patients with stage II or III esophageal cancer will receive proton therapy, and researchers will track their symptoms and quality of life using questionnaires. The goal is to see if proton therapy can reduce toxicities while still controlling the tumor as effectively as standard treatment.